In p53 wild-type lung cancer cells, the combined treatment effectively blocked the pyrimidine pool through the transcriptional activation of p53, subsequently inducing apoptosis mediated by replication stress and DNA damage [38]. Here, TP53 is linked to lung carcinoma.